FI120686B - Bentsopyraanit ja niiden käyttö terapeuttisina aineina - Google Patents

Bentsopyraanit ja niiden käyttö terapeuttisina aineina Download PDF

Info

Publication number
FI120686B
FI120686B FI964936A FI964936A FI120686B FI 120686 B FI120686 B FI 120686B FI 964936 A FI964936 A FI 964936A FI 964936 A FI964936 A FI 964936A FI 120686 B FI120686 B FI 120686B
Authority
FI
Finland
Prior art keywords
benzopyran
acetyl
dihydro
dimethyl
trans
Prior art date
Application number
FI964936A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI964936A0 (fi
FI964936A (fi
Inventor
John Morris Evans
Wai Ngor Chan
Helen Kate Ann Morgan
Mervyn Thompson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9411632A external-priority patent/GB9411632D0/en
Priority claimed from GB9411798A external-priority patent/GB9411798D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI964936A0 publication Critical patent/FI964936A0/fi
Publication of FI964936A publication Critical patent/FI964936A/fi
Application granted granted Critical
Publication of FI120686B publication Critical patent/FI120686B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
FI964936A 1994-06-10 1996-12-10 Bentsopyraanit ja niiden käyttö terapeuttisina aineina FI120686B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9411632A GB9411632D0 (en) 1994-06-10 1994-06-10 Novel treatment
GB9411632 1994-06-10
GB9411798 1994-06-13
GB9411798A GB9411798D0 (en) 1994-06-13 1994-06-13 Novel treatment
PCT/EP1995/002076 WO1995034545A1 (en) 1994-06-10 1995-05-31 Benzopyrans and their use as therapeutic agents
EP9502076 1995-05-31

Publications (3)

Publication Number Publication Date
FI964936A0 FI964936A0 (fi) 1996-12-10
FI964936A FI964936A (fi) 1997-02-06
FI120686B true FI120686B (fi) 2010-01-29

Family

ID=26305044

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964936A FI120686B (fi) 1994-06-10 1996-12-10 Bentsopyraanit ja niiden käyttö terapeuttisina aineina

Country Status (29)

Country Link
US (1) US5760074A (zh)
EP (2) EP1114821B1 (zh)
JP (2) JP3575767B2 (zh)
KR (1) KR100397721B1 (zh)
CN (2) CN1174975C (zh)
AP (1) AP714A (zh)
AT (2) ATE250052T1 (zh)
AU (1) AU701060B2 (zh)
BG (1) BG63339B1 (zh)
BR (1) BR9507980A (zh)
CA (1) CA2192480C (zh)
CY (1) CY2508B1 (zh)
CZ (1) CZ286081B6 (zh)
DE (2) DE69524871T2 (zh)
DK (2) DK1114821T3 (zh)
ES (2) ES2207590T3 (zh)
FI (1) FI120686B (zh)
HK (2) HK1001286A1 (zh)
HU (1) HUT76136A (zh)
NO (1) NO315651B1 (zh)
NZ (1) NZ287872A (zh)
OA (1) OA10593A (zh)
PL (1) PL188134B1 (zh)
PT (2) PT1114821E (zh)
RO (1) RO113463B1 (zh)
SG (1) SG67930A1 (zh)
SI (2) SI1114821T1 (zh)
SK (1) SK281456B6 (zh)
WO (1) WO1995034545A1 (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010021780A1 (en) * 1992-12-11 2001-09-13 Smithkline Beecham P.L.C. Pharmaceutical composition containing bicyclic type compounds
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment
GB9619492D0 (en) * 1996-09-18 1996-10-30 Smithkline Beecham Plc Novel treatment
US6492415B2 (en) * 1996-09-18 2002-12-10 Smithkline Beecham P.L.C. Use of benzopyranols to treat neurological disorders
GB9726543D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel compositions
GB9813949D0 (en) * 1998-06-29 1998-08-26 Smithkline Beecham Plc Novel compounds
GB0028697D0 (en) * 2000-11-23 2001-01-10 S P A Novel process
CA2602267A1 (en) * 2005-04-04 2006-10-12 Takeda Pharmaceutical Company Limited Use of ramelteon to treat and prevent depression and anxiety disorders
CA2726874A1 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
US20130281524A1 (en) * 2008-06-05 2013-10-24 Peter Blower Novel treatments
WO2011067607A1 (en) 2009-12-03 2011-06-09 Minster Research Ltd Treatment of infectious diseases
RU2012124837A (ru) 2009-12-03 2014-01-10 Проксимэджен ЛТД Лечение аллодинии и гипералгезии
EP2870148A1 (en) 2012-07-03 2015-05-13 Proximagen Limited Pro-drug compounds
GB201304814D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Pro-drug compounds
GB201322932D0 (en) * 2013-12-23 2014-02-12 Proximagen Ltd Pro-drug compounds
GB201322934D0 (en) 2013-12-23 2014-02-12 Proximagen Ltd Prodrug compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126311B1 (en) * 1983-05-18 1989-09-13 Beecham Group Plc Benzopyran derivatives.
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
NZ258610A (en) * 1992-12-11 1997-05-26 Smithkline Beecham Plc Various 4-acylamino-2h-benzo[b]pyran-3-ol derivatives;use in preparation of medicaments
DK0673374T3 (da) * 1992-12-11 2000-07-31 Smithkline Beecham Corp Farmaceutisk præparat, der indeholder bicykliske forbindelsestyper
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists

Also Published As

Publication number Publication date
SK158796A3 (en) 1997-07-09
DK1114821T3 (da) 2004-02-02
ES2207590T3 (es) 2004-06-01
ATE211469T1 (de) 2002-01-15
CZ361796A3 (en) 1997-08-13
JPH10501251A (ja) 1998-02-03
OA10593A (en) 2002-07-10
HK1039115A1 (en) 2002-04-12
PL317579A1 (en) 1997-04-14
AP714A (en) 1998-12-23
EP0764157A1 (en) 1997-03-26
AP9600889A0 (en) 1997-01-31
JP2003238554A (ja) 2003-08-27
SI0764157T1 (en) 2002-06-30
ATE250052T1 (de) 2003-10-15
NO315651B1 (no) 2003-10-06
CN1234702C (zh) 2006-01-04
DE69531801T2 (de) 2004-07-01
DK0764157T3 (da) 2002-04-22
DE69531801D1 (de) 2003-10-23
RO113463B1 (ro) 1998-07-30
HK1039115B (zh) 2004-08-13
PL188134B1 (pl) 2004-12-31
FI964936A0 (fi) 1996-12-10
DE69524871D1 (de) 2002-02-07
EP0764157B1 (en) 2002-01-02
DE69524871T2 (de) 2002-08-22
CY2508B1 (en) 2005-12-23
FI964936A (fi) 1997-02-06
US5760074A (en) 1998-06-02
AU701060B2 (en) 1999-01-21
CA2192480A1 (en) 1995-12-21
HK1001286A1 (en) 1998-06-12
EP1114821B1 (en) 2003-09-17
CN1174975C (zh) 2004-11-10
PT1114821E (pt) 2004-02-27
JP3575767B2 (ja) 2004-10-13
SG67930A1 (en) 1999-10-19
CN1154698A (zh) 1997-07-16
KR100397721B1 (ko) 2004-04-28
AU2672795A (en) 1996-01-05
ES2170798T3 (es) 2002-08-16
WO1995034545A1 (en) 1995-12-21
BG63339B1 (bg) 2001-10-31
NO965260D0 (no) 1996-12-09
SI1114821T1 (en) 2004-02-29
BG101040A (en) 1997-08-29
CA2192480C (en) 2007-07-24
NZ287872A (en) 1998-05-27
PT764157E (pt) 2002-06-28
SK281456B6 (sk) 2001-03-12
EP1114821A1 (en) 2001-07-11
CZ286081B6 (cs) 2000-01-12
NO965260L (no) 1997-02-06
HU9603415D0 (en) 1997-02-28
CN1336369A (zh) 2002-02-20
HUT76136A (en) 1997-06-30
BR9507980A (pt) 1997-08-12

Similar Documents

Publication Publication Date Title
FI120686B (fi) Bentsopyraanit ja niiden käyttö terapeuttisina aineina
ES2218617T3 (es) Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su uso como medicamento o agente de diagnostico, asi como medicamentos que los contienen.
JP3568533B2 (ja) 二環式化合物含有の医薬組成物
KR100326968B1 (ko) 약학적 활성을 가진 이환식 화합물
JPH08504432A (ja) 治療にて有用なカリウムチャネルアクチベーター
US6211211B1 (en) Benzopyrans and their use as therapeutic agents
RU2147581C1 (ru) Бензопираны, фармацевтическая композиция на их основе и способ лечения
AU739678B2 (en) Benzopyrans and their use as therapeutic agents
US20010021780A1 (en) Pharmaceutical composition containing bicyclic type compounds
WO1994013297A1 (en) Potassium channel activators and use thereof in therapy

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120686

Country of ref document: FI

MA Patent expired